groove

Penn Center for AIDS Research

Katharine J Bar

faculty photo
Assistant Professor of Medicine
Attending Physician, Infectious Diseases, Hospital of the University of Pennsylvania
Physician, International Travel Medicine Clinic, Perelman Center for Advanced Medicine
Director, Penn CFAR Viral and Molecular Core
Department: Medicine

Contact information
502 D Johnson Pavilion
3610 Hamilton Walk
Philadelphia, PA 19104-6073
Office: (215) 573-8497
Fax: (215) 349-5111
Graduate Group Affiliations
Education:
BA (Biochemistry and African History, Honors)
Northwestern University, Evanston, IL, 1997.
MD
University of Iowa College of Medicine, Iowa City, IA, 2002.
Post-Graduate Training
Intern and Resident, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, 2002-2005.
Chief Medical Resident, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, 2005-2006.
Fellow Division of Infectious Diseases, Department of Medicine, University of Alabama School of Medicine, Birmingham, AL, 2006-2009.
Clinical and PostDoctoral Research Fellow, Division of Infectious Diseases, Department of Medicine, University of Alabama School of Medicine, Birmingham, AL, 2007-2009.
Chief Fellow Division of Infectious Disease, Department of Medicine, University of Alabama School of Medicine, Birmingham, AL, 2008-2009.
Certifications
Diplomate, National Board of Medical Examiners, 2003.
Diplomate, American Board of Internal Medicine, No. 265961, 2005.
Diplomate, American Board of Internal Medicine, Subspecialty Board, Infectious Disease, No. 265961, 2009.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

HIV care, general infectious disease care

Description of Research Expertise

We study the basic mechanisms of transmission, pathogenesis and persistence in HIV and other chronic viral infections.

Current projects include:

1. The HIV transmission bottleneck and virus phenotype in injection drug users

2. The viral dynamics of rebound viremia upon cART interruption, both in the presence and absence of treatment and curative strategies

3. The neutralization properties of SIV challenge swarms and their transmitted/founder viruses

4. The genetic signatures of Herpes Simplex Virus immune escape from vaccine pressure


Lab Personnel:

Benjamin Scheinfeld, technician
D. Brenda Salantes, graduate student

Selected Publications

O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team.: Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. N Engl J Med 385(13): 1185-1195, Sep 2021 Notes: doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4.

Weimin Liu, Ronnie M Russell, Frederic Bibollet-Ruche, Ashwin N Skelly, Scott Sherrill-Mix, Drew A Freeman, Regina Stoltz, Emily Lindemuth, Fang-Hua Lee, Sarah Sterrett, Katharine J Bar, Nathaniel Erdmann, Sigrid Gouma, Scott E Hensley, Thomas Ketas, Albert Cupo, Victor M Cruz Portillo, John P Moore, Paul D Bieniasz, Theodora Hatziioannou, Greer Massey, Mary-Beth Minyard, Michael S Saag, Randall S Davis, George M Shaw, William J Britt, Sixto M Leal Jr, Paul Goepfert, Beatrice H Hahn: Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerg Infect Dis 27(9):2454-2458(9): 2454-2458, Sep 2021 Notes: DOI: 10.3201/eid2709.211042.

O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM. : Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection. medRxiv Jun 2021 Notes: doi: 10.1101/2021.06.14.21258569.

CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication: CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. J Clin Invest 131(7): e144486, April 2021 Notes: doi: 10.1172/JCI144486.

Li H, Wang S, Lee FH, Roark RS, Murphy AI, Smith J, Zhao C, Rando J, Chohan N, Ding Y, Kim E, Lindemuth E, Bar KJ, Pandrea I, Apetrei C, Keele BF, Lifson JD, Lewis MG, Denny TN, Haynes BF, Hahn BH, Shaw GM: New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure. J Virol 71(21): e00071-21, March 2021 Notes: doi: 10.1128/JVI.00071-21.

Ziani W, Bauer A, Lu H, Wang X, Wu X, Bar KJ, Li H, Liu D, Shaw GM, Veazey RS, Xu H: Immune responses and viral persistence in SHIV.C.CH848-infected rhesus macaques. J Virol 2198(20): e02198-20, February 2021 Notes: doi: 10.1128/JVI.02198-20.

Gondim MVP, Sherrill-Mix S, Bibollet-Ruche F, Russell RM, Trimboli S, Smith AG, Li Y, Liu W, Avitto AN, DeVoto JC, Connell J, Fenton-May AE, Pellegrino P, Williams I, Papasavvas E, Lorenzi JCC, Salantes DB, Mampe F, Monroy MA, Cohen YZ, Heath S, Saag MS, Montaner LJ, Collman RG, Siliciano JM, Siliciano RF, Plenderleith LJ, Sharp PM, Caskey M, Nussenzweig MC, Shaw GM, Borrow P, Bar KJ, Hahn BH: Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. Sci Transl Med 13(576), January 2021 Notes: doi: 10.1126/scitranslmed.abd8179.

Obregon-Perko V, Bricker KM, Mensah G, Uddin F, Kumar MR, Fray EJ, Siliciano RF, Schoof N, Horner A, Mavigner M, Liang S, Vanderford T, Sass J, Chan C, Berendam SJ, Bar KJ, Shaw GM, Silvestri G, Fouda GG, Permar SR, Chahroudi A: Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4+ T Cells. J Virol 95(2): e01669-20, Dec 2020 Notes: doi: 10.1128/JVI.01669-20.

Lynn N Bertagnolli , Joseph Varriale, Sarah Sweet, Jacqueline Brockhurst , Francesco R Simonetti , Jennifer White , Subul Beg, Kenneth Lynn, Karam Mounzer, Ian Frank, Pablo Tebas, Katharine J Bar , Luis J Montaner, Robert F Siliciano, Janet D Siliciano : Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1. Proceed Nat Acad Sci 117(50): 32066-32077, Nov 2020.

Berendam SJ, Styles TM, Morgan-Asiedu PK, Tenney D, Kumar A, Obregon-Perko V, Bar KJ, Saunders KO, Santra S, De Paris K, Tomaras GD, Chahroudi A, Permar SR, Amara RR, Fouda GG: Systematic assessment of antiviral potency, breadth, and synergy of triple broadly neutralizing antibody combinations against Simian-Human Immunodeficiency Viruses. J Virol 95(3): e01667-20, Nov 2020.

back to top
Last updated: 10/12/2021
The Trustees of the University of Pennsylvania